PainReform Ltd.
PRFX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 82.6% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -10,180.2% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -10,223.3% | – |
| EPS Diluted | -32.16 | -171.329 | -197.921 | -177.233 |
| % Growth | 81.2% | 13.4% | -11.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |